Publikation

Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists.

Wissenschaftlicher Artikel/Review - 11.02.2022

Bereiche
PubMed
DOI
Kontakt

Zitation
Glatzer M, Petric P, van der Steen-Banasik E, Lössl K, Jürgenliemk-Schulz I, Niehoff P, Hermansson R, Nout R, Putora P, Plasswilm L, Nakken E, Cooper R, Tanderup K, Rovirosa A, Fokdal L, Ordeanu C, Tagliaferri L, Chargari C, Strnad V, Dimopoulos J, Šegedin B, Tselis N. Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists. Cancers (Basel) 2022; 14
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Cancers (Basel) 2022; 14
Veröffentlichungsdatum
11.02.2022
ISSN (Druck)
2072-6694
Kurzbeschreibung/Zielsetzung

There are various society-specific guidelines addressing adjuvant brachytherapy (BT) after surgery for endometrial cancer (EC). However, these recommendations are not uniform. Against this background, clinicians need to make decisions despite gaps between best scientific evidence and clinical practice. We explored factors influencing decision-making for adjuvant BT in clinical routine among experienced European radiation oncologists in the field of gynaecological radiotherapy (RT). We also investigated the dose and technique of BT.